Home › Ovarian Cancer › Virginia › Arlington

Ovarian Cancer clinical trials in Arlington, VA

46 studies for Ovarian Cancer are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

The Vanguard Study: Testing a New Way to Screen for Cancer

RecruitingHealthy volunteers welcome

Inova Schar Cancer Institute, Fairfax · 11 mi away
Inova Fair Oaks Hospital, Fairfax · 11 mi away

Ages 45 to 75 · All sexes · Updated Oct 5, 2026 · NCT06995898

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RecruitingPhase 2

Inova Fairfax Hospital, Falls Church · 4 mi away
Inova Schar Cancer Institute, Fairfax · 11 mi away

All ages · All sexes · Updated Oct 5, 2026 · NCT05564377

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

RecruitingPhase 1/2

Research Site, Fairfax · 11 mi away

Ages 18 to 130 · All sexes · Updated Oct 5, 2026 · NCT05797168

A Study of PHST001 in Advanced Solid Tumors

RecruitingPhase 1

NEXT Oncology - Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06840886

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

RecruitingPhase 1

Inova Schar Cancer Institute, Fairfax · 11 mi away
NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06270706

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RecruitingPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 19 and older · All sexes · Updated Oct 1, 2026 · NCT06586957

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

RecruitingPhase 2

Next Virginia /ID# 279684, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Oct 1, 2026 · NCT07024784

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

RecruitingPhase 1

Site 04, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07814248

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

RecruitingPhase 1

Next Virginia /ID# 278607, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07278336

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

RecruitingPhase 1/2

NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06799065

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

RecruitingPhase 2

Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

RecruitingPhase 2

Site 0322 - Inova Schar Cancer Institute, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05128825

Study of AVZO-021 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2

Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05867251

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2

NEXT Oncology Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

RecruitingPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05983432

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

RecruitingPhase 3

Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · 11 mi away

Ages 18 and older · Women · Updated Sep 17, 2026 · NCT07318558

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

RecruitingPhase 1/2

NEXT Oncology, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07109726

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

RecruitingPhase 3

Inova Schar Cancer Institute, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Sep 15, 2026 · NCT07214779

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

RecruitingPhase 2

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 to 99 · Women · Updated Sep 15, 2026 · NCT07023627

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

RecruitingPhase 1/2

Inova Schar Cancer Institute, Fairfax · 11 mi away
Next Oncology Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06303505

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

RecruitingPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06293898

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

RecruitingPhase 1

NEXT Oncology, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Sep 3, 2026 · NCT07755436

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

RecruitingPhase 3

Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · 11 mi away

Ages 18 and older · Women · Updated Sep 3, 2026 · NCT06824467

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

RecruitingPhase 1

Inova Schar Cancer Institute, Falls Church · 4 mi away

Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT06774963

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

RecruitingPhase 1

Normunity Investigational Site, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07182149

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Recruiting

Inova Fairfax Hospital, Falls Church · 4 mi away
Inova Schar Cancer Institute, Fairfax · 11 mi away
Inova Fair Oaks Hospital, Fairfax · 11 mi away

Ages 35 to 50 · Women · Updated Aug 7, 2026 · NCT04251052

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

RecruitingPhase 1/2

Clinical Trial Site, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

RecruitingPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06330064

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

RecruitingPhase 1

NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT07444814

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

RecruitingPhase 1/2

USOR Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT04657068

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07524322

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

RecruitingPhase 2

522, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Jul 16, 2026 · NCT06906341

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RecruitingPhase 1/2

USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

RecruitingPhase 1

NEXT Virginia, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Jul 6, 2026 · NCT07226427

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

RecruitingPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT04389632

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

RecruitingPhase 1/2

NEXT Oncology Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05377996

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2

NEXT, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06993844

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

RecruitingPhase 3

Inova Schar Cancer Institute, Fairfax · 11 mi away

Ages 18 and older · Women · Updated Apr 16, 2026 · NCT05659381

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

RecruitingPhase 1

NEXT Oncology Virginia, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Apr 7, 2026 · NCT07424547

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

RecruitingPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

RecruitingPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05103683

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

RecruitingPhase 1

NEXT Oncology, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jan 14, 2026 · NCT06234423

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

RecruitingPhase 1

Dren Investigational Site, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jan 7, 2026 · NCT06999187

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

RecruitingPhase 1

Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mi away

Ages 18 and older · All sexes · Updated Jan 26, 2024 · NCT05746897

About Ovarian Cancer

Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.

More about Ovarian Cancer on MedlinePlus

Ovarian Cancer trials in other cities

Other studies in Arlington

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.